← all works
Retraction Note: Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Post-publication record
OpenAlex flags this work as retracted, but it carries no matching Retraction Watch record in this frame.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Naunyn-Schmiedeberg s Archives of Pharmacology
- Topic
- Cancer, Lipids, and Metabolism
- Field
- Biochemistry, Genetics and Molecular Biology
- Canadian institutions
- University of Alberta
- Funders
- —
- Keywords
- DocetaxelBiocompatible materialSensitizationCell cycle checkpointMechanism (biology)MyricetinNanoparticleBreast cancerChemistryCellCancer researchCell cycleMaterials scienceMedicineCancerNanotechnologyBiomedical engineeringInternal medicineImmunologyBiochemistryQuercetinAntioxidant
- Has abstract in OpenAlex
- no